BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17202690)

  • 1. Characterization of novel mixed polyethyleneglycol modified liposomes.
    Sugiyama I; Sadzuka Y
    Biol Pharm Bull; 2007 Jan; 30(1):208-11. PubMed ID: 17202690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
    Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
    Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin.
    Sadzuka Y; Nakade A; Tsuruda T; Sonobe T
    J Control Release; 2003 Sep; 91(3):271-80. PubMed ID: 12932707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome.
    Sadzuka Y; Nakade A; Hirama R; Miyagishima A; Nozawa Y; Hirota S; Sonobe T
    Int J Pharm; 2002 May; 238(1-2):171-80. PubMed ID: 11996821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization and cytotoxicity of mixed PEG-DSG modified liposomes].
    Sadzuka Y; Tsuruda T; Sonobe T
    Yakugaku Zasshi; 2005 Jan; 125(1):149-57. PubMed ID: 15635286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hybridized liposome by novel modification with some polyethyleneglycol-lipids.
    Sugiyama I; Sonobe T; Sadzuka Y
    Int J Pharm; 2009 May; 372(1-2):177-83. PubMed ID: 19429278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids.
    Sugiyama I; Sadzuka Y
    Biol Pharm Bull; 2013; 36(6):900-6. PubMed ID: 23727913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [To Assess Drug Delivery System Nanocarrier at Industrial Production: Establishment of Liposomal Surface Using Physicochemical Properties].
    Sadzuka Y
    Yakugaku Zasshi; 2024; 144(1):61-69. PubMed ID: 38171797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes.
    Sugiyama I; Sadzuka Y
    Curr Drug Discov Technol; 2011 Dec; 8(4):357-66. PubMed ID: 22034853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An importance of colloid chemical characterization of liposomes for DDS in a large scale production].
    Hirota S
    Yakugaku Zasshi; 1997 Dec; 117(12):991-1005. PubMed ID: 9437906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α, ω-Cholesterol-functionalized low molecular weight polyethylene glycol as a novel modifier of cationic liposomes for gene delivery.
    Ma CC; He ZY; Xia S; Ren K; Hui LW; Qin HX; Tang MH; Zeng J; Song XR
    Int J Mol Sci; 2014 Nov; 15(11):20339-54. PubMed ID: 25383677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties of PEG-grafted liposomes.
    Sriwongsitanont S; Ueno M
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1238-44. PubMed ID: 12237543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor accumulation and cellular uptake of liposomes modified with ether-bond linked cholesterol derivatives.
    Ran R; Zhang L; Tang J; Yin YJ; Qin Y; Liu YY; Zhang ZR; He Q
    Pharmazie; 2013 Aug; 68(8):668-74. PubMed ID: 24020121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.
    Zalipsky S; Mullah N; Harding JA; Gittelman J; Guo L; DeFrees SA
    Bioconjug Chem; 1997; 8(2):111-8. PubMed ID: 9095350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin.
    Sugiyama I; Sadzuka Y
    Int J Pharm; 2013 Jan; 441(1-2):279-84. PubMed ID: 23194885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
    Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.
    Sadzuka Y; Kishi K; Hirota S; Sonobe T
    J Liposome Res; 2003 May; 13(2):157-72. PubMed ID: 12855110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion stability of poly(ethylene glycol)-cholesteryl-based lipid anchors in liposome membranes.
    Molnar D; Linders J; Mayer C; Schubert R
    Eur J Pharm Biopharm; 2016 Jun; 103():51-61. PubMed ID: 27016212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes.
    Edwards K; Johnsson M; Karlsson G; Silvander M
    Biophys J; 1997 Jul; 73(1):258-66. PubMed ID: 9199790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.